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PCardiac Imaging
High-Resolution Magnetic Resonance
Myocardial Perfusion Imaging at 3.0-Tesla
to Detect Hemodynamically Significant Coronary
Stenoses as Determined by Fractional Flow Reserve
Timothy Lockie, BSC, MBCHB,* Masaki Ishida, MD, PHD,† Divaka Perera, MD,*
Amedeo Chiribiri, MD,† Kalpa De Silva, MBBS,* Sebastian Kozerke, PHD,† Mike Marber, MD, PHD,*
Eike Nagel, MD, PHD,† Reza Rezavi, MD,† Simon Redwood, MD,* Sven Plein, MD, PHD†‡
London and Leeds, United Kingdom
Objectives The objective of this study was to compare visual and quantitative analysis of high spatial resolution cardiac
magnetic resonance (CMR) perfusion at 3.0-T against invasively determined fractional flow reserve (FFR).
Background High spatial resolution CMR myocardial perfusion imaging for the detection of coronary artery disease (CAD) has
recently been proposed but requires further clinical validation.
Methods Forty-two patients (33 men, age 57.4  9.6 years) with known or suspected CAD underwent rest and adenosine-
stress k-space and time sensitivity encoding accelerated perfusion CMR at 3.0-T achieving in-plane spatial reso-
lution of 1.2  1.2 mm2. The FFR was measured in all vessels with 50% severity stenosis. Fractional flow re-
serve 0.75 was considered hemodynamically significant. Two blinded observers visually interpreted the CMR
data. Separately, myocardial perfusion reserve (MPR) was estimated using Fermi-constrained deconvolution.
Results Of 126 coronary vessels, 52 underwent pressure wire assessment. Of these, 27 lesions had an FFR 0.75. Sen-
sitivity and specificity of visual CMR analysis to detect stenoses at a threshold of FFR 0.75 were 0.82 and 0.94
(p  0.0001), respectively, with an area under the receiver-operator characteristic curve of 0.92 (p  0.0001).
From quantitative analysis, the optimum MPR to detect such lesions was 1.58, with a sensitivity of 0.80, speci-
ficity of 0.89 (p  0.0001), and area under the curve of 0.89 (p  0.0001).
Conclusions High-resolution CMR MPR at 3.0-T can be used to detect flow-limiting CAD as defined by FFR, using both visual
and quantitative analyses. (J Am Coll Cardiol 2011;57:70–5) © 2011 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.09.019t
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ccepted September 8, 2010.issue characterization. New acquisition strategies such as
-space and time sensitivity encoding (k-t SENSE) com-
ined with acquisition at 3.0-T allow further improved
n-plane spatial resolution with favorable signal to noise
atio. High-resolution myocardial perfusion CMR at 3.0-T
an detect angiographically determined coronary disease (1),
ut coronary angiography alone has limitations as a “gold
tandard” for the detection of flow-limiting coronary steno-
is (2). Invasively measured fractional flow reserve (FFR) is
onsidered to be a more reliable measure of functional
tenosis significance (3). To date, there have been no studies
omparing the performance of high-resolution CMR myo-
ardial perfusion at 3.0-T with FFR.
ethods
ll subjects gave written informed consent in accordance
ith ethical committee approval. Forty-four patients were
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December 28, 2010/January 4, 2011:70–5 High-Resolution CMR Perfusion Compared With FFRecruited with either suspected or known coronary artery
isease (CAD). All patients underwent CMR before inva-
ive coronary studies. Exclusion criteria were contraindica-
ions for CMR or gadolinium (Gd)-contrast agents, previous
yocardial infarction, coronary artery bypass grafting, acute
oronary syndrome, impaired left ventricular (LV) function
ejection fraction 40%), and obstructive pulmonary disease.
MR protocol. CMR was performed on a 3.0-T system
Achieva, Philips Medical Systems, Best, the Netherlands)
aseline Demographics of Patient CohortTable 1 Baseline Demographics of Patient Cohort
Parameter Data (n  42)
Male 33 (78.6)
Age, yrs 57.49.6
Previous PCI 8 (19)
DM 8 (19)
Previous stroke 1 (2.3)
PVD 3 (7.1)
Smoker 9 (21.4)
Family history of IHD 11 (26.1)
Medications
Statin 31 (73.8)
Beta-blocker 20 (47.6)
Aspirin 35 (83.3)
Clopidogrel 22 (52.3)
Nitrate 17 (40.4)
Calcium-channel blocker 10 (23.8)
Nicorandil 3 (7.1)
CMR data
Resting BP (MAP), mm Hg 7811
Stress BP (MAP), mm Hg 7015
Resting HR, beats/min 7115
Stress HR, beats/min 8725
Scanning time, min 5613
Late gadolinium enhancement
Full thickness 0 (0)
Partial thickness 2 (4.7)
Adenosine symptoms 42 (100)
Adenosine complications 0 (0)
Angiographic data
Time from CMR scan, days 2.54.9 (median 0.5, range 0–21)
1 lesion (50% visual diameter stenosis) 38 (90)
Vessels FFR measured (per patient), n 1.30.8
Vessels with FFR 0.75, n* 25 (0.890.06)
Vessels with FFR 0.75, n* 27 (0.530.17)
LAD, n 17
Cx, n 3
RCA, n 7
QCA in vessels with FFR 0.75
(% diameter stenosis)
4715.4
QCA in vessels with FFR 0.75
(% diameter stenosis)
81.816.3
ata are n (%) or mean SD unless otherwise indicated. *Mean SD fractional flow reserve (FFR)
s presented in parentheses.
BP  blood pressure; CMR  cardiac magnetic resonance; Cx  circumflex coronary artery;
M  diabetes mellitus; HR  heart rate; IHD  ischemic heart disease; LAD  left anterior
escending coronary artery; MAP  mean arterial pressure; PCI  percutaneous coronaryS
ntervention; PVD peripheral vascular disease; QCA quantitative coronary angiography; RCA
ight coronary artery.sing a 6-channel cardiac phased
rray receiver coil. Perfusion data
ere acquired in 3 LV short-axis
lices at end-inspiration with a
aturation recovery gradient echo
ethod (repetition time/echo
ime 3.0 ms/1.0 ms, flip angle 15°,
ffective k-t SENSE acceleration
ith 5-fold acceleration and 11
raining profiles, giving a net ac-
eleration of 3.8-fold, spatial reso-
ution 1.2 1.2 10 mm3). Data
ere acquired during adenosine-
nduced hyperemia (140 g/kg/
in) and 15 min later at rest using
.05 mmol/kg Gd-diethylene tri-
mine pentaacetic acid (Magnevist,
chering, Germany) at 4 ml/s followed by a 20-ml saline flush.
ate Gd enhancement images were acquired after 15 min.
atheter laboratory protocol. A 6-F sheath was inserted
nto the right femoral artery for coronary angiography and a
-F sheath into the right femoral vein to record right atrial
ressure (4). One milligram of intracoronary isosorbide
initrate was administered. The FFR was measured using
tandard methods (3) with a 0.014-inch coronary pressure
ensor–tipped wire (Volcano Therapeutics, San Diego, Cali-
ornia) in all vessels that showed a 50% diameter stenosis in
orthogonal views; lesser diameter stenoses were considered
ot significant. Operators in the catheter laboratory were
linded to the results of the CMR scan. Quantitative coronary
ngiography (QCA) was calculated for all lesions offline
Medcon Ltd., Tel Aviv, Israel) by a blinded observer.
isual CMR analysis. Two experienced, blinded observers
isually analyzed CMR images independently (ViewForum,
hilips Medical Systems). Defects were reported for 3
erfusion territories if contrast enhancement was delayed
elative to a remote segment or if a transmural enhancement
radient was seen (5). In case of disagreement, arbitration
rom a third observer was sought.
uantitative analysis. Two separate experienced observers
erformed blinded quantitative analysis of perfusion CMR
ata. Endocardial and epicardial borders were outlined and
region of interest placed in the LV cavity (MASS, Medis,
eiden, the Netherlands). Each slice was divided into 6
quiangular segments (5). Signal intensity/time data were
mported to a Fermi function deconvolution algorithm
mplemented in Matlaboratory (The MathWorks Inc.,
atick, Massachusetts) (6). Myocardial perfusion reserve
MPR) was calculated by dividing the hyperemic myocardial
lood flow estimate flow by resting flow. The segments were
hen assigned to the respective perfusion territory (5), and
he mean value of the 2 lowest scoring segments for each
erfusion territory was used for further analysis.
tatistical analysis. Data are presented as mean  SD.
roup means were compared using paired and unpaired
Abbreviations
and Acronyms
CAD  coronary artery
disease
CMR  cardiac magnetic
resonance
FFR  fractional flow
reserve
k-t SENSE  k-space and
time sensitivity encoding
LV  left ventricle
MPR  myocardial
perfusion reserve
QCA  quantitative
coronary angiographytudent t test as appropriate. Receiver-operating characteristic
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High-Resolution CMR Perfusion Compared With FFR December 28, 2010/January 4, 2011:70–5ROC) analysis was used to determine the diagnostic accuracy
f visual analysis and to determine the MPR with the greatest
ensitivity and specificity to detect coronary disease at an FFR
ut-off of 0.75. Linear regression was used for correlation of
PR with FFR and QCA, which were compared using Seiger
test. An interobserver reliability analysis was performed for
he discrete data using the Cohen kappa statistic and for the
ontinuous data using the coefficient of variability. Because 3
oronary territories were examined per patient, the intraclass
orrelation coefficient (ICC) was calculated to determine the
esign effect and the need to adjust these data for clustering (7).
esults
wo of the 44 recruited patients (33 men, age 57.4  9.6
ears) were excluded: 1 because of claustrophobia and 1
Figure 1 Visual CMR Analysis
Left-hand column shows (A) normal cardiac magnetic resonance (CMR) perfusion
artery, and (C) fractional flow reserve (FFR) in the vessel of 0.98 signifying non–flo
lesion in the proximal LAD, and (C) FFR of 0.69 suggesting flow-limiting lesion.wing to technical problems. A total of 126 coronary
erritories in 42 patients were thus available for analysis
Table 1).
oronary angiography. Data are shown in Table 1. An-
iography was performed 2.5  4.9 days after the CMR
can. Of the 126 vessels analyzed, 53 (42.1%) contained a
50% diameter stenosis on visual assessment and under-
ent FFR evaluation. One vessel was not assessed because
f a total occlusion. Twenty-seven of the remaining 52
esions had an FFR 0.75, and 25 lesions had an FFR
0.75. There was a good correlation between FFR and
iameter stenosis (r0.76 [95% confidence interval [CI]:
0.83 to 0.66], p  0.0001). Subsequent QCA did not
eveal any vessel with 50% diameter stenosis that was not
ssessed by FFR.
(B) moderate angiographic lesion in left anterior descending (LAD) coronary
ting disease. Right-hand column shows (A) anterior perfusion defect, (B) tightscan,
w-limi
C
a
(
o
f
V
a
f
k
i
0
v
r
C
v

i
0
0
a
T
(
T
0
Q
C
l
a
w
M
o
c
C
w
0
T
0
b
73JACC Vol. 57, No. 1, 2011 Lockie et al.
December 28, 2010/January 4, 2011:70–5 High-Resolution CMR Perfusion Compared With FFRMR imaging. Mean scanning time was 56  13 min,
nd there were no complications from the adenosine. Two
4.7%) patients had evidence of subendocardial scar based
n the late Gd enhancement images; none had evidence of
ull-thickness transmural scar.
isual CMR analysis versus FFR. Perfusion was reported
s abnormal for 30 coronary territories (23.8%) and normal
or 96 territories (Fig. 1). The interobserver reliability was
appa 0.79 (95% CI: 0.69 to 0.91, p 0.0001). The FFR
n vessels with a visually detected perfusion defect was
.59 0.22 and was 0.93 0.09 (p 0.0001) in those with
isually normal perfusion. Conversely, 22 of the 27 territo-
ies with an FFR 0.75 had a perfusion defect on visual
MR analysis. Five perfusion defects were reported in 99
essels that were angiographically normal or had an FFR
0.75. Sensitivity of CMR perfusion to detect coronary
schemia at a threshold of FFR 0.75 was 0.82 (95% CI:
.61 to 0.93), specificity 0.94 (95% CI: 0.87 to 0.98, p 
.001), positive predictive value 0.83 (95% CI: 0.65 to 0.94),
nd negative predictive value 0.94 (95% CI: 0.88 to 0.98).
he likelihood ratio was 16 with an area under the curve
AUC) of 0.92 (95% CI: 0.85 to 0.99, p  0.0001) (Fig. 2).
he agreement between visual analysis and FFR was kappa 
.76 (95% CI: 0.63 to 0.89, p  0.0001).
uantitative analysis. In 4 patients, quantitative analysis of
MR perfusion data was not possible because of artifacts,
eaving 114 perfusion territories in 38 patients available for
nalysis. The MPR in the 24 territories with an FFR  0.75
as 1.35 0.5. In the 90 territories in which FFR was0.75,
Figure 2 ROC Showing Sensitivity and Specificity
of Visual CMR Perfusion Analysis
Receiver-operating characteristic (ROC) showing sensitivity and specificity of
CMR perfusion visual analysis to detect a hemodynamically significant coronary
stenosis using a dichotomous value of 0.75 for FFR. The area under the curve
was 0.92. Abbreviations as in Figure 1.PR was 2.2 0.5 (p 0.0001). On ROC analysis, an MPR
f 1.58 provided optimal sensitivity and specificity to detect
oronary ischemia at the threshold of FFR0.75 of 0.80 (95%
I: 0.58 to 0.94) and 0.89 (95% CI: 0.8 to 0.95), respectively,
ith positive and negative predictive values of 0.73 (95% CI:
.54 to 0.88) and 0.95 (95% CI: 0.88 to 0.98), respectively.
his gave a likelihood ratio of 9.3 and AUC of 0.89 (95% CI:
.8 to 0.98, p  0.0001) (Figs. 3 and 4). The agreement
etween MPR and FFR was kappa  0.70 (95% CI: 0.54 to
Figure 3 ROC Showing Sensitivity and Specificity
of Quantitative CMR Perfusion Analysis by MPR
ROC showing sensitivity and specificity of myocardial perfusion reserve (MPR)
to detect a hemodynamically significant coronary stenosis using a dichotomous
value of 0.75 for FFR. The area under the curve was 0.89. Abbreviations as in
Figures 1 and 2.
Figure 4 Scatter Plot Showing Distribution
of MPR Values According to FFR
A dichotomous cut-off of 0.75 was used to signify a
significant lesion. Abbreviations as in Figures 1 and 3.
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High-Resolution CMR Perfusion Compared With FFR December 28, 2010/January 4, 2011:70–5.86, p  0.0001). The coefficient of interobserver variability
or MPR was 18%.
inear regression. Linear regression analysis showed a
loser correlation between MPR and FFR (r  0.59 [95%
I: 0.43 to 0.71]; p  0.0001) than between MPR and
CA (r  0.47 [95% CI: 0.61 to 0.29], p  0.0001;
 4.73, p  0.0001). The ICC was low (r1  0.03 [95%
I: 0.19 to 0.771], p  0.6) with a design effect  1.06
here cluster size  3.
iscussion
his study showed that high-resolution myocardial perfu-
ion CMR imaging can be used for the detection of
unctionally significant coronary artery stenosis as deter-
ined by FFR using both visual and quantitative analysis.
MR-based measurements of myocardial blood flow cor-
elated better with FFR than with QCA.
The majority of previous studies that have validated
MR myocardial perfusion imaging used QCA to deter-
ine the lesion severity. Our results showed that for
igh-resolution CMR perfusion data acquired at 3.0-T,
isual and quantitative CMR allowed for accurate localiza-
ion of perfusion defects to coronary territories.
Estimates of MPR correlated more closely with func-
ional assessment of stenosis severity by FFR than with
natomic assessment by QCA. Previously, Rieber et al. (8)
ssessed a standard CMR perfusion sequence at 1.5-T for
he detection of FFR-determined coronary disease in 43
atients. A semiquantitative analysis of upslopes of the
ignal-intensity profiles yielded sensitivity and specificity of
8% and 90%, respectively (8). Visual analysis was not
erformed. By comparison, Watkins et al. (9) used visual
nalysis of CMR perfusion alone with FFR in the assess-
ent of 103 patients with CAD and were able to detect
unctionally significant disease with similarly high accuracy.
n this later study, 25% of the patients had acute coronary
yndrome and 23% had evidence of prior myocardial infarc-
ion. Although FFR has been used in these settings (10), its
pplicability remains uncertain (11). In addition, the pres-
nce of acutely injured myocardium or variable amounts of
car may have an unpredictable effect on the visual inter-
retation of myocardial perfusion. For these reasons, such
atients were not included in the present study.
Both visual and quantitative analyses of myocardial per-
usion CMR data have not been performed in previous
tudies. Although visual analysis of CMR perfusion is
idely used in clinical practice, most current quantitative
nalysis methods are time consuming. In the present study,
uantitative analysis yielded a degree of interobserver and
ntraobserver variability similar to previously published val-
es (12), and both analysis methods were able to detect
ignificant CAD as determined by FFR. The optimal MPR
ut-off value of 1.58 to discriminate accurately between
emodynamically significant and nonsignificant lesions in
his study is consistent with previous reports (8,13,14). It isossible that temporal filtering effects may have rendered
he quantitative analysis less accurate. Such effects can be
imited with recently proposed improvements of the k-t
ENSE method that were not available at the time this
tudy was performed (15).
tudy limitations. Consistent with clinical practice, FFR
as only measured in vessels with 50% coronary stenosis.
e have studied a population with a very high prevalence of
AD who were already listed for invasive studies so that our
ata need to be considered preliminary and the reported
ccuracy is likely to represent a best-case scenario. The
pplicability of our results to a population with a lower
re-test probability of significant CAD needs to be deter-
ined, and the accuracy may well be lower. Artifacts may be
problem with the k-t SENSE method because of respira-
ory or cardiac motion, and quantitative analysis was not
ossible in 4 cases because of this. Such problems may be
ccentuated in patients with tachyarrhythmia or an inability
o breath-hold for the scan. Because 3 perfusion territories
ere examined per patient, there is the potential for data
oss through clustering. Although the design effect of this
as low owing to a small ICC and cluster size, our results
ay have overestimated data correlations.
onclusions
n patients with stable coronary disease, high-resolution
MR perfusion at 3.0-T detected hemodynamically signif-
cant coronary stenoses as determined by FFR, using both
isual and quantitative analysis methods.
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